Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Helle Knudsen
Observed names:
H Knudsen,
H. KNUDSEN,
H. Knudsen,
Helle Ekkert Knudsen,
Helle KNUDSEN,
Knudsen, Helle
show all 6
Institutions:
Herlev Hospital,
Gentofte Hospital
Observed institutions:
University of Copenhagen,
Aarhus University,
Odense University Hospital,
Herlev Hospital,
Aarhus University Hospital,
Copenhagen University Hospital,
Gentofte Hospital,
Rigshospitalet
show all 8
OpenAlex ID:
A5061205262
Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group
2008
·
Marianne Kyndi
, Flemming B. Sørensen
, et al.
·
Journal of Clinical Oncology
·
564
Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group
2005
·
Ann S. Knoop
, Helle Knudsen
, et al.
·
Journal of Clinical Oncology
·
319
Antisense Properties of Duplex- and Triplex-Forming PNAs
1996
·
H. Knudsen
, P. E. Nielsen
·
Nucleic Acids Research
·
257
MYC translocation partner gene determines survival of patients with large B‐cell lymphoma with MYC ‐ or double‐hit MYC / BCL 2 translocations
2013
·
Mette Ø. Pedersen
, Anne O. Gang
, et al.
·
European Journal Of Haematology
·
123
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c
2008
·
Marianne Kyndi
, Marie Overgaard
, et al.
·
Radiotherapy and Oncology
·
114
The value ofTOP2Agene copy number variation as a biomarker in breast cancer: Update of DBCG trial 89D
2008
·
Kirsten Vang Nielsen
, Bent Ejlertsen
, et al.
·
Acta Oncologica
·
109
PDF
Double‐hit BCL 2/ MYC translocations in a consecutive cohort of patients with large B‐cell lymphoma – a single centre's experience
2012
·
Mette Ø. Pedersen
, Anne O. Gang
, et al.
·
European Journal Of Haematology
·
99
Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
2008
·
M. Kyndi
, F. B. Sørensen
, et al.
·
Acta Oncologica
·
74
PDF
Cellular Uptake of Adamantyl Conjugated Peptide Nucleic Acids
1999
·
Trine Ljungstrøm
, Helle Knudsen
, et al.
·
Bioconjugate Chemistry
·
73
Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes
2004
·
Karen E. Olsen
, Helle Knudsen
, et al.
·
Acta Oncologica
·
72
PDF
World Health Organization‐defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations—The Danish experience
2013
·
Ann Brinch Madelung
, Henrik Bondo
, et al.
·
American Journal of Hematology
·
60
PDF
Application of peptide nucleic acid in cancer therapy
1997
·
Helle Knudsen
, Peter E Nielsen
·
Anti-Cancer Drugs
·
43
A common response element mediates differential effects of phorbol esters and forskolin on type‐1 plasminogen activator inhibitor gene expression in human breast carcinoma cells
1994
·
Helle KNUDSEN
, Tina OLESEN
, et al.
·
European Journal of Biochemistry
·
39
PDF
CD34+ megakaryoblastic leukaemic cells are CD38−, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
1997
·
C Helleberg
, H Knudsen
, et al.
·
Leukemia
·
26
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers
2017
·
Mette Ølgod Pedersen
, Anne Ortved Gang
, et al.
·
PLoS ONE
·
21
PDF
Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c
2008
·
M. Kyndi
, F. B. Sørensen
, et al.
·
Acta Oncologica
·
21
PDF
Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
1995
·
P B Hansen
, H Knudsen
, et al.
·
PubMed
·
19
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials
2008
·
Marianne Kyndi
, Flemming B Sørensen
, et al.
·
Breast Cancer Research
·
18
PDF
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma
2014
·
Anne O. Gang
, Mette Ø. Pedersen
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
14
Stratification by MYC expression has prognostic impact in MYC translocated B‐cell lymphoma—Identifies a subgroup of patients with poor outcome
2019
·
Mette Ølgod Pedersen
, Anne Ortved Gang
, et al.
·
European Journal Of Haematology
·
12
TOP2A aberrations as predictive and prognostic marker in high-risk breast cancer patients. A randomized DBCG Trial (DBCG89D)
2006
·
A. Knoop
, H. Knudsen
, et al.
·
Journal of Clinical Oncology
·
11
PD‐L1 expression is low in large B‐cell lymphoma with MYC or double‐hit translocation
2019
·
Mette Vestergaard Elbæk
, Mette Ølgod Pedersen
, et al.
·
Hematological Oncology
·
8
PDF
WHO classification 2008 of myeloproliferative neoplasms: a workshop learning effect – the Danish experience
2015
·
Ann B. Madelung
, Henrik Bondo
, et al.
·
Apmis
·
7
674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D)
2003
·
A. Knoop
, H. Knudsen
, et al.
·
European Journal of Cancer Supplements
·
7
High‐grade B‐cell lymphomas with MYC and BCL2 translocations lack tumor‐associated macrophages and PD‐L1 expression: A possible noninflamed subgroup
2021
·
Marie F. Breinholt
, Douglas V. N. P. Oliveira
, et al.
·
Hematological Oncology
·
5
Show more works
View as search
Works count:
38
Citation count:
2,134
H-index:
18
I10-index:
21
Year
Topic
Type
